Review article<br>Pharmacodynamics, pharmacokinetics, drug interactions, toxicity and clinical efficacy of proton pump inhibitors – are the differences significant?

Paweł Petryszyn; Abdulhabib Annabhani; Leszek Paradowski

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2008
vol. 3

Send email

Copy url:

abstract:

Review article
Pharmacodynamics, pharmacokinetics, drug interactions, toxicity and clinical efficacy of proton pump inhibitors – are the differences significant?

Paweł Petryszyn

,

Abdulhabib Annabhani

,

Leszek Paradowski

Przegląd Gastroenterologiczny 2008; 3 (1): 56–61

Online publish date: 2008/03/04

View full text Get citation

Proton pump inhibitors (omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole) are commonly used for the treatment of gastro-oesophageal reflux disease and other acid-related gastrointestinal disorders as well. They all have a broadly similar mechanism of action and are metabolised in the liver via cytochrome P450 (CYP). They all have proved to be highly effective and generally safe. Different activation rates, binding sites within the H⁺/K⁺-ATPase and contribution of each CYP isoenzyme in their metabolism may produce differences in the potential for drug interactions and toxicity as well as onset and level of acid suppression. However, there is very little evidence to state that the differences in clinical efficacy of the five proton pump inhibitors are significant.

keywords:

Review articlePharmacodynamics, pharmacokinetics, drug interactions, toxicity and clinical efficacy of proton pump inhibitors – are the differences significant?

Paweł Petryszyn , Abdulhabib Annabhani , Leszek Paradowski

proton pumps, pharmacokinetics, drug interactions, treatment outcome

Review article
Pharmacodynamics, pharmacokinetics, drug interactions, toxicity and clinical efficacy of proton pump inhibitors – are the differences significant?

Paweł Petryszyn

,

Abdulhabib Annabhani

,

Leszek Paradowski